Invivyd (IVVD) Cash & Equivalents (2020 - 2026)

Invivyd (IVVD) has reported Cash & Equivalents for 7 consecutive years, with $160.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 358.62% year-over-year to $160.1 million; the trailing twelve-month figure through Jun 2026 stood at $160.1 million (up 358.62% YoY), and the FY2025 full-year result was $226.7 million, up 226.88% from the prior year.
• Cash & Equivalents fell to $160.1 million in Q2 2026 per IVVD's latest filing, from $226.7 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $532.2 million in Q1 2022 and bottomed at $34.9 million in Q2 2025.
• Historically, Cash & Equivalents has averaged $181.0 million across 5 years, with a median of $147.9 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Cash & Equivalents sank 83.02% in 2022, then jumped 358.62% in 2026.
• Over 5 years, Cash & Equivalents stood at $92.1 million in 2022, then surged by 117.91% to $200.6 million in 2023, then plunged by 65.44% to $69.3 million in 2024, then jumped by 226.88% to $226.7 million in 2025, then decreased by 29.38% to $160.1 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $160.1 million, $226.7 million, and $85.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.